SEER Inquiry System - Report
Produced: 11/24/2024 9:02 PM
Question 20110015
Inquiry Details
References:
SEER Errata for ICD-O-3 Site/Type Validation List. April 1, 2009
Question:
Primary site/Histology: Do the 4/1/09 changes in the ICD-O-3 Site/Type Validation table regarding the coding of primary site for intestinal type adenocarcinoma mean that the former valid site/histology combinations are now impossible and require review from a given diagnosis date forward? See Discussion.
Discussion:
Per the SEER Errata for ICD-O-3 Site/Type Validation List, April 1, 2009, adenocarcinoma, intestinal type, was removed as a valid site/histology combination for the following primary sites: C150-C155, C158-C159, C170-C173, C178-C179, C180-C189, C199, C209, C210-C212, C218.
Answer:
The site/type edit identifies unlikely combinations of primary site and histologic type.
Cancer Site Category:
N/A
Data Item Category:
Primary site, Histology
Other Category:
N/A
Year:
2011